Figure 2From: Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial Kaplan Meier survival curves representing the probability of being free of nT2L lesions throughout the study period under de-escalation therapy with INFB or continued NTZ. Back to article page